姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Liu,Zong-Xi | Chairman | 17.00% | |
Pan,Xian | Independent Director | 0.00% | |
Xu,Da-Ren | Independent Director | 0.00% | |
Shi,Xin-Chuan | Independent Director | 0.00% | |
Shao,Yu-Ling | Independent Director | 0.00% | |
Xiao,Yu-Qiao | Director | 0.00% | |
Xu,Guang-Hui | Director | 0.00% | |
OSVALDO VAZQUEZ MURILLO | Director | 0.00% |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Operating income | 778,890 | 2,511,442 | 2,564,771 |
Operating cost | 554,281 | 1,753,754 | 1,731,277 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 224,609 | 757,688 | 833,494 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 224,609 | 757,688 | 833,494 |
Operating expenses | 63,153 | 233,435 | 218,132 |
Other gain (loss), net | - | 0 | 0 |
Operating profit (loss) | 161,456 | 524,253 | 615,362 |
Non-operating income and expenses | 14,584 | 74,472 | 40,676 |
Net profit (loss) before tax | 176,040 | 598,725 | 656,038 |
Income tax expense (benefits) | 35,255 | 109,147 | 126,249 |
Net profit (loss) of ongoing business for the current period | 140,785 | 489,578 | 529,789 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | 140,785 | 489,578 | 529,789 |
Other comprehensive profit (loss), net | - | - | - |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | 140,785 | 489,578 | 529,789 |
Net profit (loss) attributable to owners of parent company | - | - | - |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | 1 | 6 | 7 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | - | - | - |
Net cash inflows (outflows) from investing activities | - | - | - |
Net cash inflow (outflow) from financing activities | - | - | - |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
Beginning balance of cash and cash equivalents | - | - | - |
Ending balance of cash and cash equivalents | - | - | - |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Current asset | 2,452,311 | 2,247,060 | 1,987,854 |
Non-current asset | 1,351,426 | 1,347,185 | 1,263,162 |
Total asset | 3,803,737 | 3,594,245 | 3,251,016 |
Current liability | 1,097,694 | 636,389 | 570,767 |
Non-current liability | 536,322 | 559,897 | 436,800 |
Total liability | 1,634,016 | 1,196,286 | 1,007,567 |
share capital | 786,152 | 784,819 | 713,565 |
Equity - secruity token | - | - | - |
capital reserve | 652,331 | 645,892 | 646,481 |
retained earning | 731,238 | 967,248 | 905,576 |
Other equity | 0 | 0 | -22,173 |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | - | - | - |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 2,169,721 | 2,397,959 | 2,243,449 |
Share capital awaiting retirement (unit: share) | - | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 27 | 30 | 31 |